Only the beginning of precision medicine and multiple myeloma.
Advancements in APL treatment: oral ATO, MRD and treatment objectives
Cessation of venetoclax and remaining in remission from CLL?
Combining radiotherapy and the immune system in lymphomas
ADCT-402 - a drug to watch